Publications

Sort by: Date | Author | Title

Peluso, A. A., Lundgaard, A. T., Babaei, P., Mousovich-Neto, F., Rocha, A. L., Damgaard, M. V., Bak, E. G., Gnanasekaran, T., Dollerup, O. L., Trammell, S. A. J., Nielsen, T. S., Kern, T., Abild, C. B., Sulek, K., Ma, T., Gerhart-Hines, Z., Gillum, M. P., Arumugam, M., Ørskov, C. ... Treebak, J. T. (2023). Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans. npj Aging, 9(1), 1-21. Article 7. https://doi.org/10.1038/s41514-023-00106-4
Philpott, C., Kumaresan, K., Fjaeldstad, A. W., Macchi, A., Monti, G., Frasnelli, J., Konstantinidis, I., Pinto, J., Mullol, J., Boardman, J., Vodicka, J., Holbrook, E., Ramakrishnan, V. R., Lechner, M. & Hummel, T. (2023). Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative. Rhinology, 61(4), 312-319. https://doi.org/10.4193/Rhin22.116
Pihl, R., Zheng, Q. & David, Y. (2023). Nature-inspired protein ligation and its applications. Nature Reviews Chemistry, 7(4), 234-255. https://doi.org/10.1038/s41570-023-00468-z
Pluznick, J. L. & Fenton, R. A. (2023). Perspective on G protein-coupled receptors in renal physiology. American Journal of Physiology - Renal Physiology, 325(6), F683-F684. https://doi.org/10.1152/ajprenal.00307.2023
Rajagopal, V. M., Ganna, A., Coleman, J. R. I., Allegrini, A., Voloudakis, G., Grove, J., Als, T. D., Horsdal, H. T., Petersen, L., Appadurai, V., Schork, A., Buil, A., Bulik, C. M., Bybjerg-Grauholm, J., Bækvad-Hansen, M., Hougaard, D. M., Mors, O., Nordentoft, M., Werge, T. ... Demontis, D. (2023). Genome-wide association study of school grades identifies genetic overlap between language ability, psychopathology and creativity. Scientific Reports, 13, Article 429. https://doi.org/10.1038/s41598-022-26845-0
Ramiro, S., Poddubnyy, D., Mease, P. J., López-Medina, C., Fleurinck, C., Kim, M., Massow, U., Taieb, V., Kragstrup, T. W. & Mcgonagle, D. (2023). POS0247 RESOLUTION OF ENTHESITIS AND PERIPHERAL ARTHRITIS WITH BIMEKIZUMAB IN PATIENTS WITH AXIAL SPODYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES. Annals of the Rheumatic Diseases, 82(Suppl 1), 358-359. https://doi.org/10.1136/annrheumdis-2023-eular.831